Silexion Therapeutics (SLXN) Q1 2025 Earnings
SLXN·Reported May 13, 2025·Before market open
Diluted EPS came in at $-3.90, missed the $-0.22 consensus by $3.68.
Diluted EPS
$-3.90missed by $3.68
Consensus: $-0.22
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Silexion Therapeutics's Q1 2025 earnings report.
Silexion Therapeutics (SLXN) reported Q1 2025 earnings on May 13, 2025 before market open.
Silexion Therapeutics reported diluted EPS of $-3.90 for Q1 2025.
EPS missed the consensus estimate of $-0.22 by $3.68.
You can read the 10-Q periodic report (0001178913-25-001761) directly on SEC EDGAR. The filing index links above go to sec.gov.